Evercore ISI reiterates Constellation Brands stock rating on guidance

Evercore ISI reiterated an Outperform on Constellation Brands with a $170 price target while the stock trades at $150.26 and analyst targets span roughly $120–$220. Management guided FY2027 beer net sales of -1% to +1% (volumes -3% to flat, pricing +1% to +2%), and analysts flagged conservative topline guidance but positive near-term depletion trends (Evercore notes a projected +2% beer depletions for the quarter). Multiple brokers raised/maintained bullish ratings and price targets (UBS $176, Goldman $180, RBC $185, Roth/MKM $209) despite some below-consensus EPS estimates (UBS EPS $1.59), so monitor March trends and commentary on capital allocation under the new CEO ahead of the Q4 report.

Analysis

Constellation’s advisor-driven optimism masks a classic two‑part story: a near‑term demand beat (March quarter depletions) that can trigger multiple expansion, and a longer‑term beer volume contraction that management is already baking into guidance. That dynamic creates asymmetric outcomes — a short, sharp upside on an earnings/print beat and a drawn‑out valuation compression if volumes don’t stabilize as consumers trade down or channel mix shifts.

Second‑order winners from a conservative guidance posture include upstream input contractors (glass, aluminum, hops) where reduced beer volumes lower working capital needs and can push suppliers to consolidate or reprioritize capacity; conversely, spirits/wine peers could capture margin share if Constellation levers its higher‑margin portfolio to offset beer weakness. Competitive exposure matters: large brewers with scale in value segments could win shelf share if STZ chooses to defend margins over share, while private label and on‑prem recovery pace remain the wildcards.

Key catalysts are clear and short dated: the upcoming call (near weeks) and subsequent March depletion datapoints will move multiples quickly; the medium horizon (6–12 months) is the new CEO’s capital allocation reveals — buyback vs M&A vs debt paydown will reprice equity and credit. Tail risks that would reverse the constructive near‑term view are macro discretionary pullback, unexpected tax/excise policy, or a supply shock to packaging costs; these are higher‑impact over quarters not days, so size and optionality matter for positioning.

Key Decisions for Investors

• Long STZ via 3–6 month call spread (buy 1 ATM call, sell 1 15–20% OTM call) ahead of the earnings call window. Rationale: captures a short, high‑conviction earnings beat with defined max loss (premium paid) and 2–4x upside if depletions surprise. Size 2–4% portfolio, exit on 30–50% realized gain or if depletions miss expectations by a wide margin.
• Pair trade: long STZ equity / short BUD (equal $ exposure) for 3–6 months to isolate exposure to Constellation’s premiumization and cap allocation optionality versus large brewer execution. Target 10–20% relative outperformance; cut the pair if STZ underperforms by 8% relative or if macro discretionary indicators (consumer sentiment or real retail sales) worsen materially.
• Volatility play: buy near‑term (1–3 month) straddle sized small (0.5–1% portfolio) into the call to capture binary move on the earnings conference call; hedge by selling a portion of longer‑dated calls (calendar spread) to monetize time decay if you expect post‑print calm. Close post‑print or after implied vol falls >40% from pre‑call levels.
• Monitor credit/corporate action: prepare to accumulate STZ USD IG bonds on any >50bp spread widening versus peers in a 3–12 month window if management signals buybacks/M&A — asymmetry exists because strong buyback signaling would compress spreads and re‑rate equity. Trade size: opportunistic, focused on carry vs event risk.